Terms: = Liver cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH
173 results:
1. Non-small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?
Li Y; Gong B; Guo Y; Liu W; Chen C; Jiang S; Pan F; Song J; Yang L; Zhou G
BMC Cancer; 2024 Apr; 24(1):535. PubMed ID: 38671373
[TBL] [Abstract] [Full Text] [Related]
2. Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.
Li CMY; Briggs MT; Lee YR; Tin T; Young C; Pierides J; Kaur G; Drew P; Maddern GJ; Hoffmann P; Klingler-Hoffmann M; Fenix K
Clin Exp Med; 2024 Mar; 24(1):53. PubMed ID: 38492056
[TBL] [Abstract] [Full Text] [Related]
3. Adjuvant treatment with Cordyceps sinensis for lung cancer: A systematic review and meta-analysis of randomized controlled trials.
Wang C; Wang J; Qi Y
J Ethnopharmacol; 2024 Jun; 327():118044. PubMed ID: 38484953
[TBL] [Abstract] [Full Text] [Related]
4. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
[TBL] [Abstract] [Full Text] [Related]
5. The value of varying diffusion curvature MRI for assessing the microvascular invasion of hepatocellular carcinoma.
Zhang Y; Sheng R; Dai Y; Yang C; Zeng M
Abdom Radiol (NY); 2024 Apr; 49(4):1154-1164. PubMed ID: 38311671
[TBL] [Abstract] [Full Text] [Related]
6. Urinary microbiome-based metagenomic signature for the noninvasive diagnosis of hepatocellular carcinoma.
Cho EJ; Kim B; Yu SJ; Hong SK; Choi Y; Yi NJ; Lee KW; Suh KS; Yoon JH; Park T
Br J Cancer; 2024 Apr; 130(6):970-975. PubMed ID: 38278977
[TBL] [Abstract] [Full Text] [Related]
7. Association of Neighborhood Deprivation and Transplant Center Quality with liver Transplantation Outcomes.
Munir MM; Endo Y; Mehdi Khan MM; Woldesenbet S; Yang J; Washburn K; Limkemann A; Schenk A; Pawlik TM
J Am Coll Surg; 2024 Mar; 238(3):291-302. PubMed ID: 38050968
[TBL] [Abstract] [Full Text] [Related]
8. Identification of patients with favorable prognosis after resection in intermediate-stage-hepatocellular carcinoma.
Lee HA; Lee M; Yoo JJ; Chun HS; Park Y; Kim HY; Kim TH; Seo YS; Sinn DH
Int J Surg; 2024 Feb; 110(2):1008-1018. PubMed ID: 38016294
[TBL] [Abstract] [Full Text] [Related]
9. Association between pro-inflammatory diet and liver cancer risk: a systematic review and meta-analysis.
Chen K; Yang F; Zhu X; Qiao G; Zhang C; Tao J; Gao X; Xiao M
Public Health Nutr; 2023 Dec; 26(12):2780-2789. PubMed ID: 37990536
[TBL] [Abstract] [Full Text] [Related]
10. Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million Patients.
Beheshti Maal A; Shahrbaf MA; Sadri B; Hossein-Khannazer N; Mansournia MA; Vosough M
J Crohns Colitis; 2024 Mar; 18(3):360-374. PubMed ID: 37695111
[TBL] [Abstract] [Full Text] [Related]
11. Weekend Effect on Clinical Outcomes of Acute Lower Gastrointestinal Bleeding: A Large Multicenter Cohort Study in Japan.
Hayasaka J; Kikuchi D; Ishii N; Kobayashi K; Yamauchi A; Yamada A; Omori J; Ikeya T; Aoyama T; Tominaga N; Sato Y; Kishino T; Sawada T; Murata M; Takao A; Mizukami K; Kinjo K; Fujimori S; Uotani T; Fujita M; Sato H; Suzuki S; Narasaka T; Funabiki T; Kinjo Y; Mizuki A; Kiyotoki S; Mikami T; Gushima R; Fujii H; Fuyuno Y; Gunji N; Toya Y; Narimatsu K; Manabe N; Nagaike K; Kinjo T; Sumida Y; Funakoshi S; Kobayashi K; Matsuhashi T; Komaki Y; Miki K; Watanabe K; Odagiri H; Hoteya S; Kaise M; Nagata N
Dig Dis; 2023; 41(6):890-899. PubMed ID: 37669627
[TBL] [Abstract] [Full Text] [Related]
12. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study.
Serra-Burriel M; Juanola A; Serra-Burriel F; Thiele M; Graupera I; Pose E; Pera G; Grgurevic I; Caballeria L; Piano S; van Kleef L; Reichert M; Roulot D; Pericàs JM; Schattenberg JM; Tsochatztis EA; Guha IN; Garcia-Retortillo M; Hernández R; Hoyo J; Fuentes M; Expósito C; Martínez A; Such P; Madir A; Detlefsen S; Tonon M; Martini A; Ma AT; Pich J; Bonfill E; Juan M; Soria A; Carol M; Gratacós-Ginès J; Morillas RM; Toran P; Navarrete JM; Torrejón A; Fournier C; Llorca A; Arslanow A; de Koning HJ; Cucchietti F; Manns M; Newsome PN; Hernáez R; Allen A; Angeli P; de Knegt RJ; Karlsen TH; Galle P; Wong VW; Fabrellas N; Castera L; Krag A; Lammert F; Kamath PS; Ginès P;
Lancet; 2023 Sep; 402(10406):988-996. PubMed ID: 37572680
[TBL] [Abstract] [Full Text] [Related]
13. ESTIMATION OF SERUM FERROPORTIN AND liver ENZYMES IN BREAST cancer PATIENTS.
Aziz Z; Sarhat E; Zaidan Z
Georgian Med News; 2023 Jun; (339):37-41. PubMed ID: 37522771
[TBL] [Abstract] [Full Text] [Related]
14. Genome-wide association study of chronic sputum production implicates loci involved in mucus production and infection.
Packer RJ; Shrine N; Hall R; Melbourne CA; Thompson R; Williams AT; Paynton ML; Guyatt AL; Allen RJ; Lee PH; John C; Campbell A; Hayward C; de Vries M; Vonk JM; Davitte J; Hessel E; Michalovich D; Betts JC; Sayers I; Yeo A; Hall IP; Tobin MD; Wain LV
Eur Respir J; 2023 Jun; 61(6):. PubMed ID: 37263751
[TBL] [Abstract] [Full Text] [Related]
15. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Shang T; Jiang T; Lu T; Wang H; Cui X; Pan Y; Xu M; Pei M; Ding Z; Feng X; Lin Y; Li X; Tan Y; Feng F; Dong H; Wang H; Dong L
Front Immunol; 2023; 14():1166497. PubMed ID: 37234171
[TBL] [Abstract] [Full Text] [Related]
16. Diabetes Mellitus Impacts on the Performance of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B Patients.
Yip TC; Wong VW; Lai MS; Lai JC; Tse YK; Liang LY; Hui VW; Chan HL; Wong GL
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2864-2875.e16. PubMed ID: 36828301
[TBL] [Abstract] [Full Text] [Related]
17. SUVmax-to-HU ratio in diagnosis of hepatic metastases of colon cancer on FDG PET/CT. A new semiquantitative parameter.
Ayaz UY; Ayaz S
Ann Ital Chir; 2023; 94():27-35. PubMed ID: 36810357
[TBL] [Abstract] [Full Text] [Related]
18. p53 promotes peroxisomal fatty acid β-oxidation to repress purine biosynthesis and mediate tumor suppression.
Zhao J; Zhou X; Chen B; Lu M; Wang G; Elumalai N; Tian C; Zhang J; Liu Y; Chen Z; Zhou X; Wu M; Li M; Prochownik EV; Tavassoli A; Jiang C; Li Y
Cell Death Dis; 2023 Feb; 14(2):87. PubMed ID: 36750554
[TBL] [Abstract] [Full Text] [Related]
19. Simultaneous versus staged resection for synchronous colorectal liver metastases: The win ratio approach.
Endo Y; Alaimo L; Araujo Lima H; Tsilimigras DI; Hyer JM; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
Am J Surg; 2023 Mar; 225(3):461-465. PubMed ID: 36435656
[TBL] [Abstract] [Full Text] [Related]
20. Sarcopaenia, obesity, sarcopaenic obesity and outcomes following hepatic resection for colorectal liver metastases: a systematic review and meta-analysis.
O'Connell RM; O'Neill M; Ó Ríordáin MG; Ó Súilleabháin CB; O'Sullivan AW
HPB (Oxford); 2022 Nov; 24(11):1844-1853. PubMed ID: 35922276
[TBL] [Abstract] [Full Text] [Related]
[Next]
